Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Children as haematopoietic stem cell donors: ethically challenging and legally complex.

Then SN, Kerridge IH, Marks M.

Med J Aust. 2018 May 7;208(8):334-337. No abstract available.

PMID:
29716509
2.

Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations.

Lysaght T, Kerridge IH, Sipp D, Porter G, Capps BJ.

J Bioeth Inq. 2017 Jun;14(2):261-273. doi: 10.1007/s11673-017-9776-y. Epub 2017 Feb 28. Review.

PMID:
28247202
3.

Gene editing advance re-ignites debate on the merits and risks of animal to human transplantation.

Fung RK, Kerridge IH.

Intern Med J. 2016 Sep;46(9):1017-22. doi: 10.1111/imj.13183.

PMID:
27633468
4.

How shortcomings in the mental health system affect the use of involuntary community treatment orders.

Light EM, Robertson MD, Boyce P, Carney T, Rosen A, Cleary M, Hunt GE, O'Connor N, Ryan CJ, Kerridge IH.

Aust Health Rev. 2017 Jul;41(3):351-356. doi: 10.1071/AH16074.

PMID:
27414238
5.

Ethical considerations in the management of Ebola virus disease.

Solano T, Gilbert GL, Kerridge IH, Nayyar V, Berry A.

Med J Aust. 2015 Aug 17;203(4):193-5e.1.

PMID:
26268293
6.

Part of the fabric and mostly right: an ethnography of ethics in clinical practice.

Doran E, Fleming J, Jordens C, Stewart CL, Letts J, Kerridge IH.

Med J Aust. 2015 Jun 15;202(11):587-90.

PMID:
26068692
7.

The scourge of managerialism and the Royal Australasian College of Physicians.

Komesaroff PA, Kerridge IH, Isaacs D, Brooks PM.

Med J Aust. 2015 Jun 1;202(10):519-21. No abstract available.

PMID:
26021355
8.

Religious Perspectives on Human Suffering: Implications for Medicine and Bioethics.

Fitzpatrick SJ, Kerridge IH, Jordens CFC, Zoloth L, Tollefsen C, Tsomo KL, Jensen MP, Sachedina A, Sarma D.

J Relig Health. 2016 Feb;55(1):159-173. doi: 10.1007/s10943-015-0014-9. Review.

PMID:
25680422
9.

Managing ethical issues in patient care and the need for clinical ethics support.

Doran E, Fleming J, Jordens C, Stewart CL, Letts J, Kerridge IH.

Aust Health Rev. 2015 Feb;39(1):44-50. doi: 10.1071/AH14034.

PMID:
25514126
10.

Don't be scared, be angry: the politics and ethics of Ebola.

Hooker LC, Mayes C, Degeling C, Gilbert GL, Kerridge IH.

Med J Aust. 2014 Sep 15;201(6):352-4.

PMID:
25222463
11.

Knowledge, beliefs, and decisions of pregnant Australian women concerning donation and storage of umbilical cord blood: a population-based survey.

Jordens CF, Kerridge IH, Stewart CL, O'Brien TA, Samuel G, Porter M, O'Connor MA, Nassar N.

Birth. 2014 Dec;41(4):360-6. doi: 10.1111/birt.12121. Epub 2014 Jul 2.

PMID:
24988997
12.

The lived experience of involuntary community treatment: a qualitative study of mental health consumers and carers.

Light EM, Robertson MD, Boyce P, Carney T, Rosen A, Cleary M, Hunt GE, O'Connor N, Ryan C, Kerridge IH.

Australas Psychiatry. 2014 Aug;22(4):345-351. Epub 2014 Jun 24.

PMID:
24963099
13.

Privacy in the context of "re-emergent" infectious diseases.

Denholm JT, Kerridge IH.

J Bioeth Inq. 2014 Jun;11(2):263-4. doi: 10.1007/s11673-014-9517-4. Epub 2014 Apr 27. No abstract available.

PMID:
24771523
14.

Double meanings will not save the principle of double effect.

Douglas CD, Kerridge IH, Ankeny RA.

J Med Philos. 2014 Jun;39(3):304-16. doi: 10.1093/jmp/jhu011. Epub 2014 Apr 15.

PMID:
24737837
15.

The economic evaluation of personalised oncology medicines: ethical challenges.

Lewis JR, Lipworth WL, Kerridge IH, Day RO.

Med J Aust. 2013 Oct 7;199(7):471-3.

PMID:
24099207
16.

The quality of Australian health journalism is important for public health.

Jordens CF, Lipworth WL, Kerridge IH.

Med J Aust. 2013 Oct 7;199(7):448-9. No abstract available.

PMID:
24099189
17.

Ethical and legal issues raised by cord blood banking - the challenges of the new bioeconomy.

Stewart CL, Aparicio LC, Kerridge IH.

Med J Aust. 2013 Aug 19;199(4):290-2.

PMID:
23984790
18.

Religious perspectives on the use of psychopharmaceuticals as an enhancement technology.

Fitzpatrick SJ, Jordens CF, Kerridge IH, Keown D, Walter JJ, Nelson P, Abdalla M, Lehmann LS, Sarma D.

J Relig Health. 2014 Oct;53(5):1440-55. Review.

PMID:
23959744
19.

Intimacy or utility? Organ donation and the choice between palliation and ventilation.

Bendorf A, Kerridge IH, Stewart C.

Crit Care. 2013 May 23;17(3):316. doi: 10.1186/cc12553. Review.

20.

Socioeconomic, demographic and policy comparisons of living and deceased kidney transplantation rates across 53 countries.

Bendorf A, Pussell BA, Kelly PJ, Kerridge IH.

Nephrology (Carlton). 2013 Sep;18(9):633-40. doi: 10.1111/nep.12101.

PMID:
23692370
21.

Challenges to a more open discussion of suicide.

Fitzpatrick SJ, Kerridge IH.

Med J Aust. 2013 May 20;198(9):470-1. No abstract available.

PMID:
23682878
22.

An international comparison of the effect of policy shifts to organ donation following cardiocirculatory death (DCD) on donation rates after brain death (DBD) and transplantation rates.

Bendorf A, Kelly PJ, Kerridge IH, McCaughan GW, Myerson B, Stewart C, Pussell BA.

PLoS One. 2013 May 7;8(5):e62010. doi: 10.1371/journal.pone.0062010. Print 2013.

23.

Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials.

Deakin CT, Alexander IE, Hooker CA, Kerridge IH.

Mol Ther. 2013 Apr;21(4):806-15. doi: 10.1038/mt.2012.230. Epub 2013 Jan 22.

24.

Survey of practices and policies relating to the use of complementary and alternative medicines and therapies in New South Wales cancer services.

Raszeja VM, Jordens CF, Kerridge IH.

Intern Med J. 2013 Jan;43(1):84-8. doi: 10.1111/imj.12010.

PMID:
23324089
25.

Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization.

Lipworth WL, Kerridge IH, Day RO.

Ther Innov Regul Sci. 2013 Jan;47(1):46-49. doi: 10.1177/2168479012469949.

PMID:
30227492
26.

"Good mothering" or "good citizenship"?

Porter M, Kerridge IH, Jordens CF.

J Bioeth Inq. 2012 Mar;9(1):41-7. doi: 10.1007/s11673-011-9343-x. Epub 2011 Dec 27.

PMID:
23180199
27.

Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency.

Lipworth WL, Ho K, Kerridge IH, Day RO.

Med J Aust. 2012 Aug 20;197(4):204-5. No abstract available.

PMID:
22900859
28.

Medicine and science must oppose intolerance and censorship.

Komesaroff PA, Moore A, Kerridge IH.

Med J Aust. 2012 Jul 16;197(2):82-3. No abstract available.

PMID:
22794044
29.

Tempering hope with realism: induced pluripotent stem cells in regenerative medicine.

Fung RK, Kerridge IH, Skene LL, Munsie MJ.

Med J Aust. 2012 Jun 4;196(10):622-5. No abstract available.

PMID:
22676869
30.

Out of sight, out of mind: making involuntary community treatment visible in the mental health system.

Light EM, Kerridge IH, Ryan CJ, Robertson MD.

Med J Aust. 2012 May 21;196(9):591-3.

PMID:
22621153
31.

Racially conditional donation: the example of umbilical cord blood.

Komesaroff PA, Kerridge IH, Stewart C, Samuel G, Lipworth W, Jordens CF.

J Law Med. 2012 Mar;19(3):517-24.

PMID:
22558904
32.

Umbilical cord blood banking: beyond the public-private divide.

O'Connor MA, Samuel G, Jordens CF, Kerridge IH.

J Law Med. 2012 Mar;19(3):512-6.

PMID:
22558903
33.

Religious perspectives on umbilical cord blood banking.

Jordens CF, O'Connor MA, Kerridge IH, Stewart C, Cameron A, Keown D, Lawrence RJ, McGarrity A, Sachedina A, Tobin B.

J Law Med. 2012 Mar;19(3):497-511.

PMID:
22558902
34.

Beyond evidence: reappraising use of CA-125 as post-therapy surveillance for ovarian cancer.

Harnett P, Kerridge IH, Jordens CF, Hobbs K, Mason C, Morrell BM.

Med J Aust. 2012 Apr 16;196(7):440-1. No abstract available.

PMID:
22509867
35.

Access to the kidney transplant waiting list: a time for reflection.

Pussell BA, Bendorf A, Kerridge IH.

Intern Med J. 2012 Apr;42(4):360-3. doi: 10.1111/j.1445-5994.2012.02730.x.

PMID:
22498116
36.

Explaining failure through success: a critical analysis of reduction in road and stroke deaths as an explanation for Australia's low deceased organ donation rates.

Bendorf A, Kerridge IH, Kelly PJ, Pussell B, Guasch X.

Intern Med J. 2012 Aug;42(8):866-73. doi: 10.1111/j.1445-5994.2012.02792.x.

PMID:
22471995
37.

Wrong questions, wrong answers? Are we getting the drugs we need?

Lipworth WL, Kerridge IH, Day RO.

Clin Pharmacol Ther. 2012 Mar;91(3):367-9. doi: 10.1038/clpt.2011.335. No abstract available.

PMID:
22343808
38.

A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group.

George B, Kerridge IH, Gilroy N, Huang G, Hertzberg MS, Bradstock KF, Gottlieb DJ.

Transpl Infect Dis. 2012 Apr;14(2):141-8. doi: 10.1111/j.1399-3062.2011.00706.x. Epub 2012 Jan 29.

PMID:
22283838
39.

Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment.

Inam S, Lipworth WL, Kerridge IH, Day RO.

Med J Aust. 2011 Oct 17;195(8):446-7. No abstract available.

PMID:
22004386
40.

Ethical issues in bone marrow transplantation in children.

Bendorf A, Kerridge IH.

J Paediatr Child Health. 2011 Sep;47(9):614-9. doi: 10.1111/j.1440-1754.2011.02165.x.

PMID:
21951444
41.

Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.

Fung RK, Kerridge IH.

Bioethics. 2013 Feb;27(2):89-96. doi: 10.1111/j.1467-8519.2011.01896.x. Epub 2011 Jul 4.

PMID:
21726264
42.

Narratives of 'terminal sedation', and the importance of the intention-foresight distinction in palliative care practice.

Douglas CD, Kerridge IH, Ankeny RA.

Bioethics. 2013 Jan;27(1):1-11. doi: 10.1111/j.1467-8519.2011.01895.x. Epub 2011 Jul 4.

PMID:
21726263
43.

Progress in stem cell research and the role of law.

Kerridge IH, Bendorf A.

Med J Aust. 2011 Feb 21;194(4):156-7. No abstract available.

PMID:
21401451
44.

Journal peer review in context: A qualitative study of the social and subjective dimensions of manuscript review in biomedical publishing.

Lipworth WL, Kerridge IH, Carter SM, Little M.

Soc Sci Med. 2011 Apr;72(7):1056-63. doi: 10.1016/j.socscimed.2011.02.002. Epub 2011 Feb 18.

PMID:
21388730
45.

The perils of a vanishing cohort: a study of social comparisons by women with advanced ovarian cancer.

Morrell B, Jordens CF, Kerridge IH, Harnett P, Hobbs K, Mason C.

Psychooncology. 2012 Apr;21(4):382-91. doi: 10.1002/pon.1909. Epub 2011 Feb 4.

PMID:
21294222
46.

Evidence, ethics, and values: a framework for health promotion.

Carter SM, Rychetnik L, Lloyd B, Kerridge IH, Baur L, Bauman A, Hooker C, Zask A.

Am J Public Health. 2011 Mar;101(3):465-72. doi: 10.2105/AJPH.2010.195545. Epub 2011 Jan 13.

47.

Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer.

Jordens CF, Morrell B, Harnett P, Hobbs K, Mason C, Kerridge IH.

Soc Sci Med. 2010 Nov;71(9):1548-56. doi: 10.1016/j.socscimed.2010.07.033. Epub 2010 Aug 26.

PMID:
20832155
48.

Attitudes of physicians and public to pharmaceutical industry 'gifts'.

Macneill PU, Kerridge IH, Newby D, Stokes BJ, Doran E, Henry DA.

Intern Med J. 2010 May;40(5):335-41. doi: 10.1111/j.1445-5994.2010.02233.x. Epub 2010 Mar 23.

PMID:
20345507
49.

Direct-to-consumer personal genome testing: the problem is not ignorance--it is market failure.

Jordens CF, Kerridge IH, Samuel GN.

Am J Bioeth. 2009;9(6-7):13-5. doi: 10.1080/15265160902874411. No abstract available.

PMID:
19998103
50.

Supplemental Content

Loading ...
Support Center